Works by Peluso, Teresa


Results: 17
    1

    Cereblon gene expression and correlation with clinical outcomes in patients with relapsed/refractory multiple myeloma treated with pomalidomide: an analysis of STRATUS.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 2, p. 462, doi. 10.1080/10428194.2018.1485915
    By:
    • Qian, Xiaozhong;
    • Amatangelo, Michael;
    • Bjorklund, Chad;
    • Towfic, Fadi;
    • Flynt, Erin;
    • Yu, Xin;
    • Peluso, Teresa;
    • Sternas, Lars;
    • Zaki, Mohamed;
    • Thakurta, Anjan;
    • Dimopoulos, Meletios A.;
    • Weisel, Katja C.;
    • Ocio, Enrique M.;
    • Moreau, Philippe
    Publication type:
    Article
    2

    P-224: Pomalidomide, bortezomib, and dexamethasone after 1 prior line of therapy in relapsed or refractory multiple myeloma (RRMM): A safety subanalysis of the phase 3 OPTIMISMM trial.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S163, doi. 10.1016/S2152-2650(21)02351-X
    By:
    • Weisel, Katja;
    • Dimopoulos, Meletios-Athanasios;
    • Oriol, Albert;
    • Beksac, Meral;
    • Dimopoulos, Fredrik;
    • Liberati, Anna Marina;
    • Lindsay, Jindriska;
    • White, Darrell;
    • San-Miguel, Jesús F.;
    • Moreau, Philippe;
    • Anderson Jr., Larry D.;
    • Lorocca, Alessandra;
    • Robak, Pawef;
    • Vogel, Prisca;
    • Jiang, Ruiyun;
    • Grote, Lara;
    • Peluso, Teresa;
    • Richardson, Paul G.
    Publication type:
    Article
    3

    P-203: EXCALIBER: a phase 3 study comparing iberdomide, daratumumab, and dexamethasone (IberDd) with daratumumab, bortezomib, and dexamethasone (DVd) in patients with relapsed or refractory multiple myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S150, doi. 10.1016/S2152-2650(21)02330-2
    By:
    • Lonial, Sagar;
    • Berdeja, Jesus G.;
    • Dimopoulos, Meletios-Athanasios;
    • Jagannath, Sundar;
    • Knop, Stefan;
    • Hang Quach;
    • Rodríguez-Otero, Paula;
    • Richardson, Paul G.;
    • Sorrell, April;
    • Min Chen;
    • Kueenburg, Elisabeth;
    • Tuong Vi Nguyen;
    • Hong, Kevin;
    • Peluso, Teresa;
    • van de Donk, Niels W.C.J.
    Publication type:
    Article
    4
    5

    Modulation of NK, T, & B cell sub-populations by Pomalidomide predicts favorable progression-free survival (PFS): Results from a large randomized clinical trial in relapsed/refractory myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e167, doi. 10.1016/j.clml.2019.09.279
    By:
    • Rao, Prabhal;
    • Samur, Mehmet;
    • Talluri, Srikanth;
    • Derebail, Sanika;
    • Potluri, Lakshmi;
    • Haas, Eric;
    • Buonopane, Michael;
    • Heubeck, Alexander;
    • Fulciniti, Mariateresa;
    • Lazo-Kallanian, Suzan;
    • Hong, Kevin;
    • Peluso, Teresa;
    • john daley;
    • Biyukov, Tsvetan;
    • Beksac, Meral;
    • Dimopoulos, Meletios A.;
    • mohamad hussain;
    • Pierceall, William;
    • Richardson, Paul G.;
    • Anderson, Kenneth C.
    Publication type:
    Article
    6
    7

    Pomalidomide + Bortezomib + Dexamethasone After One Prior Line of Therapy in Bortezomib-Pretreated Multiple Myeloma: Subanalysis of OPTIMISMM.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e32, doi. 10.1016/j.clml.2019.09.048
    By:
    • Dimopoulos, Meletios A.;
    • Weisel, Katja;
    • Moreau, Philippe;
    • Anderson, Larry D.;
    • White, Darrell;
    • San-Miguel, Jesus;
    • Sonneveld, Pieter;
    • Engelhardt, Monika;
    • Jenner, Matthew;
    • Corso, Alessandro;
    • Dürig, Jan;
    • Pavic, Michel;
    • Salomo, Morten;
    • Casalz, Eva;
    • Jiang, Ruiyun;
    • Srinivasan, Shankar;
    • Nguyen, Tuong Vi;
    • Bensmaine, Amine;
    • Peluso, Teresa;
    • Richardson, Paul G.
    Publication type:
    Article
    8
    9
    10

    Pomalidomide, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Survival and Subgroup Analyses From the OPTIMISMM Trial.

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 5, p. 822, doi. 10.1111/ejh.14365
    By:
    • Richardson, Paul;
    • Beksaç, Meral;
    • Oriol, Albert;
    • Lindsay, Jindriska;
    • Schjesvold, Fredrik;
    • Galli, Monica;
    • Yağcı, Münci;
    • Larocca, Alessandra;
    • Weisel, Katja;
    • Yu, Xin;
    • Donahue, Cynthia;
    • Acosta, Jorge;
    • Peluso, Teresa;
    • Dimopoulos, Meletios
    Publication type:
    Article
    11

    Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival.

    Published in:
    Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1271807
    By:
    • Prabhala, Rao;
    • Pierceall, William E.;
    • Samur, Mehmet;
    • Potluri, Lakshmi B.;
    • Hong, Kevin;
    • Peluso, Teresa;
    • Talluri, Srikanth;
    • Wang, Angela;
    • Katiki, Aishwarya;
    • Vangala, Sahan D.;
    • Buonopane, Michael;
    • Bade, Vaishnavi;
    • Seah, Hannah;
    • Krogman, Arthur;
    • Derebail, Sanika;
    • Fulciniti, Mariateresa;
    • Lazo, Suzan B.;
    • Richardson, Paul;
    • Anderson, Kenneth;
    • Corre, Jill
    Publication type:
    Article
    12
    13
    14

    Brain Abnormalities in Young Single- and Double-Heterozygote Mice for Both Nkx2-1- and Pax8-Null Mutations.

    Published in:
    Molecular Neurobiology, 2025, v. 62, n. 4, p. 4023, doi. 10.1007/s12035-024-04524-7
    By:
    • Giacco, Antonia;
    • Iervolino, Stefania;
    • Cioffi, Federica;
    • Peluso, Teresa;
    • Mercurio, Giovanna;
    • Roberto, Luca;
    • de Rosa, Valeria;
    • Cammarota, Mariarosaria;
    • Varricchio, Silvia;
    • Staibano, Stefania;
    • Boscia, Francesca;
    • Canzoniero, Lorella Maria Teresa;
    • De Felice, Mario;
    • Ambrosino, Concetta;
    • Moreno, Maria;
    • Silvestri, Elena
    Publication type:
    Article
    15
    16
    17